Cargando…
Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience
BACKGROUND: The number of cases of novel coronavirus disease 2019 (COVID-19) in Japan have risen since the first case was reported on January 24, 2020, and 6225 infections have been reported as of June 30, 2020. On April 8, 2020, our hospital began screening patients via pre-admission reverse transc...
Autores principales: | Nogami, Yuya, Kobayashi, Yusuke, Tsuji, Kosuke, Yokota, Megumi, Nishio, Hiroshi, Nakamura, Masaru, Yamagami, Wataru, Morisada, Tohru, Tominaga, Eiichiro, Banno, Kouji, Aoki, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485922/ https://www.ncbi.nlm.nih.gov/pubmed/32917254 http://dx.doi.org/10.1186/s13048-020-00711-x |
Ejemplares similares
-
Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors (Review)
por: Umene, Kiyoko, et al.
Publicado: (2019) -
Clinical utility of MR spectroscopy for gynecological pelvic abscesses using next-generation sequencing technology for the detection of causative bacteria
por: Nogami, Yuya, et al.
Publicado: (2023) -
New candidate therapeutic agents for endometrial cancer: Potential for clinical practice (Review)
por: UMENE, KIYOKO, et al.
Publicado: (2013) -
Profiling of the Causative Bacteria in Infected Lymphocysts after Lymphadenectomy for Gynecologic Cancer by Pyrosequencing the 16S Ribosomal RNA Gene Using Next-Generation Sequencing Technology
por: Nogami, Yuya, et al.
Publicado: (2019) -
Current status of molecular-targeted drugs for endometrial cancer (Review)
por: NOGAMI, YUYA, et al.
Publicado: (2013)